---
category: news
title: "Arch Biopartners Receives Health Canada Approval to Conduct COVID-19 Phase II Human Trial"
excerpt: "Arch Biopartners Inc., (“Arch&CloseCurlyDoubleQuote; or the “Company&CloseCurlyDoubleQuote;) (TSX Venture: ARCH and OTCQB: ACHFF) a clinical stage company developing new drug candidates for treating organ damage caused by inflammation,"
publishedDateTime: 2020-05-08T10:04:00Z
webUrl: "https://stockhouse.com/news/press-releases/2020/05/08/arch-biopartners-receives-health-canada-approval-to-conduct-covid-19-phase-ii"
type: article
quality: 41
heat: 41
published: false

provider:
  name: Stockhouse
  domain: stockhouse.com

topics:
  - Coronavirus in Canada
  - Coronavirus

tags:
  - CA

secured: "oq9oP4ojydnYnPoemRExNnDD7bE4q5I3Vr2lVjcS8baiHkRC95oN8Ok+nMeRTDPwJJ+U9JqNXJH2FE2sdvMudCGF1GgiqjKcnrjE5EuNHgIw7wnmGY99hNGG/5JrvuNJ+t6zDK1vMBKPS+29hmD8TtlH/xmqLCdguAyOKrOOVf2RGyGevWDYsKppNn26gbYILYQhu4dR3BIfytSk2beQaM8Mq0evZz+2COznIAZV4XduC2HbVMsztSd+0Uan/ZZTGy8OuBW1c5C5COHKColMSoy6lLQSulJ7XCazaFSY36AgFkkcBZC9Wrf3p9gvM+6OqZaFx3nOqnlsI+5dpEqsN/UaotL0HJmYLjagM+0i/7AhxuwvnNtGEcCv2RyH1DRmbKvoVQYmn0GGS01mk3Ny0MAs3hSU0PEV+Lhgsp6JCAV2s8uO4+I34r5SV+3zFMIUydBZYfrOtJsqelGgvCL9TuAQDp/2z3CqH7xbetM5I3c=;FfoRxqT/80evBYtyhc/K3Q=="
---

